IR Pharma company logo
  • Company overview
  • Meet the team
  • Profile
  • Why we're different;
  • Technology - The drug development process at IRP; The Drug Evaluation Process; Model systems
  • Portfolio
  • Contact us

  • Respiratory Pharmacology pre-clinical drug discovery to the biopharma and pharma industries

    Diary

    IR Pharma will have a presence
    at the following conferences.
    Contact us to arrange
    a meeting with one of the team.




    May 19-24, 2017
    American Thoracic Society
    Annual Conference.
    Washington DC, USA.


    September 9-13, 2017
    European Respiratory Society
    Congress.
    Milan, Italy.







    Read about
    IR Pharma in




    Academic excellence,
    industry expertise . . .



    IR Pharma provides the pharmaceutical industry with Respiratory Pharmacology pre-clinical drug discovery through short, focused projects and larger, wide ranging system-based discovery programmes. Timely delivery of study objectives that add value to client lead compounds and technology are a high priority for the company.

    Based on the world leading academic expertise of the Respiratory Pharmacology group at the National Heart and Lung Institute, Imperial College, led by Professor Maria Belvisi and Dr Mark Birrell, the team, in addition, boasts an extensive industry background.

    Providing an outstanding combination of scientific insights and practical solutions to address the pre-clinical needs of industry clients, the team offers:


    • A responsive business interface for addressing enquiries;
    • rapid early feedback on project feasibility;
    • project management through discovery phases.

    The quality of the service provided by IR Pharma is endorsed by a prestigious list of past clients that have chosen the team to evaluate their lead compounds and in many cases design their screening pathway, advise on translational studies and appropriate clinical partnerships.

    In addition to general mechanistic models, specific disease models are available in:


    • Asthma;
    • Chronic Obstructive Pulmonary Disease (COPD);
    • Cough.

    IR Pharma can provide an unrivalled combination of assays, models and current scientific thinking to provide solutions that represent outstanding value.